MedTrace Logo

Changes in Viral Load in COVID-19 After Probiotics

NCT04666116 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2020-12-16

No results posted yet for this study

Summary

The main objective of the study is to evaluate the capacity of a novel nutritional supplement intervention including strains from the species Bifidobacterium longum, Bifidobacterium animalis subsp. Lactis and Lactobacillus rhamnosus, plus vitamin D, zinc and seleniumt) (immune system enhancer, antioxidant and anti-inflammatory capacity) to decrease the viral load by nasopharyngeal smear in patients admitted for COVID-19 coronavirus disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Dietary supplementation in patients with covid disease admitted to hospital

Dietary supplementation in patients with covid disease admitted to hospital

Sponsors & Collaborators

  • Biopolis S.L.

    collaborator INDUSTRY

  • Laboratorios Heel España

    collaborator UNKNOWN

  • Hospital de Sagunto

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-12-31
Completion
2021-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04666116 on ClinicalTrials.gov